Hair Loss Treatment Products Market was worth US$ xx million in 2021, and it is estimated to reach a valuation of US$ xx million by the end of 2026, expanding at a CAGR of 4.2% Hair Loss can be the result of a variety of malignant tumors resulting in thinning hair or baldness. This will lead to hair loss, especially among middle-aged and old-aged people.
Recent Developments:
Hair Loss Treatment Products Market Growth:
The global market for hair loss treatment products is growing at a rapid pace with significant growth in trichology centers in recent years, and the market is further likely to grow with more demand during the forecast period.
Hair Loss Treatment Products Market Drivers:
Hair loss is an essential issue for men and women around the world. Men suffer from alopecia for a long time due to androgenetic alopecia or general male baldness. However, in recent years, hair loss in women is increasing due to external factors such as environmental pollution and chemicals. Lifestyle changes, such as excessive intake of alcohol, tobacco, and related products, increased stress levels, are considered powerful triggers for alopecia. The exact cause is unknown, but some cases are associated with genetic factors. Also, higher disposable income and greater emphasis on aesthetic appearance are supposed to contribute to the demand for hair loss treatment products.
According to the American Academy of Dermatology, around 40% of women have visible hair loss when they are 40 years old. In most cases, women's hair loss affects the appearance and emotional well-being. Therefore, the American Hair Loss Association recognized that hair loss in women is a condition that changes dangerous lives that can no longer be ignored. Hormonal imbalances and diseases are the leading causes of hair loss. In such cases, hair loss often reverses naturally because the subject experiences unpredictable growth and shedding patterns. The main drivers of the market are changes in lifestyle patterns, the adoption of busy schedules that increase the level of stress, which leads to frequent hair loss in the early stages of the young population, higher disposable income, and greater emphasis on appearance.
Moreover, the increasing trichology clinics and advances in the technology for the regrowth of hair, along with the wide range of products available in the market, are anticipated to result in tremendous growth opportunities for the market players in the next few years.
Hair Loss Treatment Products Market Restraints:
The presence of alternative treatment options for hair loss, such as hair transplant surgery, laser and phototherapy, and expensive drug costs will limit the market in the prognosis period.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2021–2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 - 2026 |
|
CAGR |
4.2% |
|
Segments Covered |
According to the type of disease, By end-user, According to the sales channel |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Histogen Inc., Concert Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Alès Groupe, Merck & Co., Inc., Alpecin, Vitabiotics Ltd., Sun Pharmaceutical Industries Ltd., Aclaris Therapeutics Inc., GlaxoSmithKline, Johnson and Johnson, Lifes2good, Daiichi Sankyo, Inc., Cipla and HCell Inc. |
Regional Analysis:
North America has a large market for hair loss treatment and will dominate the business during the forecast period followed by Europe. According to the American Hair Loss Association, more than 80 million men and women suffer from hair loss problems in the United States alone. There are several beneficial initiatives taken by organizations such as NAAF and the American Hair Loss Association. According to Eurostat, the population of the European Union between 15 and 60 years is expected to decrease by 2060, and the population over 60 is expected to increase from 18% to 30%. Similarly, in the United States, population aging is expected to double by 2060, reaching 990 million. The increase in hair loss caused by aging has had a significant impact on market growth.
Key Players:
Key companies in the Hair Loss Treatment Products Market are Histogen Inc., Concert Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Alès Groupe, Merck & Co., Inc., Alpecin, Vitabiotics Ltd., Sun Pharmaceutical Industries Ltd., Aclaris Therapeutics Inc., GlaxoSmithKline, Johnson and Johnson, Lifes2good, Daiichi Sankyo, Inc., Cipla and HCell Inc.
1. Introduction
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.1.1 Drivers
4.1.2 Restaints
4.1.3 Opportunities
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.2 Products/Service
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 Hair Loss Treatment Products Market, By Disease Type
6.1.1 Alopecia Areata
6.1.2 Cicatricial Alopecia
6.1.3 Traction Alopecia
6.1.4 Alopecia Totalis
6.1.5 Alopecia Universalis
6.1.6 Androgenetic Alopecia
6.1.7 Market Size Estimations & Forecasts (2021-2026)
6.1.8 Y-o-Y Growth Rate Analysis
6.1.9 Market Attractiveness Index
6.2 Hair Loss Treatment Products Market, By End-Use
6.2.1 Homecare Settings
6.2.2 Dermatology Clinics
6.2.3 Market Size Estimations & Forecasts (2021-2026)
6.2.4 Y-o-Y Growth Rate Analysis
6.2.5 Market Attractiveness Index
6.3 Hair Loss Treatment Products Market, By Sales Channel
6.3.1 Over the Counter (OTC)
6.3.2 Prescription
6.3.3 Market Size Estimations & Forecasts (2021-2026)
6.3.4 Y-o-Y Growth Rate Analysis
6.3.5 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 North America - Market Analysis (2021- 2026)
7.2.1 By Country
7.2.1.1 USA
7.2.1.2 Canada
7.2.2 By Disease Type
7.2.3 By End-Use
7.2.4 By Sales Channel
7.3 Europe
7.3.1 By Country
7.3.1.1 UK
7.3.1.2 France
7.3.1.3 Germany
7.3.1.4 Spain
7.3.1.5 Italy
7.3.1.6 Rest of Europe
7.3.2 By Disease Type
7.3.3 By End-Use
7.3.4 By Sales Channel
7.4 Asia Pacific
7.4.1 By Country
7.4.1.1 China
7.4.1.2 India
7.4.1.3 Japan
7.4.1.4 South Korea
7.4.1.5 South East Asia
7.4.1.6 Australia & NZ
7.4.1.7 Rest of Asia-Pacific
7.4.2 By Disease Type
7.4.3 By End-Use
7.4.4 By Sales Channel
7.5 Latin America
7.5.1 By Country
7.5.1.1 Brazil
7.5.1.2 Argentina
7.5.1.3 Mexico
7.5.1.4 Rest of Latin America
7.5.2 By Disease Type
7.5.3 By End-Use
7.5.4 By Sales Channel
7.6 Middle East and Africa
7.6.1 By Country
7.6.1.1 Middle East
7.6.1.2 Africa
7.6.2 By Disease Type
7.6.3 By End-Use
7.6.4 By Sales Channel
8. Key Player Analysis
8.1 Histogen Inc.,
8.1.1 Business Description
8.1.2 Products/Service
8.1.3 Financials
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Concert Pharmaceuticals Inc.
8.3 Dr. Reddy's Laboratories Ltd.
8.4 Alès Groupe
8.5 Merck & Co., Inc
8.6 Alpecin, Vitabiotics Ltd.
8.7 Sun Pharmaceutical Industries Ltd
8.8 GlaxoSmithKline
8.9 Johnson and Johnson
8.10 Cipla
8.11 Daiichi Sankyo, Inc.
8.12 Hcell Inc.
9.MarketOutlook&Investment Opportunities
Appendix
List of Tables
List of Figures
